FDA warns against use of Skippack Medical Lab COVID-19 Antigen Test
The FDA is concerned about the risk of false results when using this test because it says SML Distribution LLC has not provided the FDA with adequate data to show the test works correctly.
•
May 11, 2022, 10:40 AM
•
Updated 956 days ago
Share:
More Stories
Nobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
447ds ago1:25
Pharmacies say they have not received orders for newest COVID booster
452ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
459ds ago0:41
Gov. Hochul: Updated COVID-19 vaccine to be available in NY in the coming days
466ds ago2:13
NYSDOH: COVID numbers up with new variant accounting for 17% of new cases
500ds ago2:30
NYSHD: Hospitalizations caused by COVID increase by 22% in a week
508ds agoNobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
447ds ago1:25
Pharmacies say they have not received orders for newest COVID booster
452ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
459ds ago0:41
Gov. Hochul: Updated COVID-19 vaccine to be available in NY in the coming days
466ds ago2:13
NYSDOH: COVID numbers up with new variant accounting for 17% of new cases
500ds ago2:30
NYSHD: Hospitalizations caused by COVID increase by 22% in a week
508ds agoThe
U.S. Food and Drug Administration is warning people not to use the
Skippack Medical Lab SARS-CoV-2 Antigen Rapid Test (Colloidal Gold).
According to the FDA, the test is not authorized, cleared, or approved by the FDA for distribution or use in the United States.
The FDA is concerned about the risk of false results when using this test because it says SML Distribution LLC has not provided the FDA with adequate data to show the test works correctly.
The FDA says it has not received reports of injuries or death associated with use of the Skippack Medical Lab SARS-CoV-2 Antigen Rapid Test (Colloidal Gold).
According to the FDA, the test is not authorized, cleared, or approved by the FDA for distribution or use in the United States.
The FDA is concerned about the risk of false results when using this test because it says SML Distribution LLC has not provided the FDA with adequate data to show the test works correctly.
The FDA says it has not received reports of injuries or death associated with use of the Skippack Medical Lab SARS-CoV-2 Antigen Rapid Test (Colloidal Gold).
More from News 12
1:37
Stony Brook Medicine doctor shares advice on staying safe amid frigid temperatures
1:47
BITTER BLAST: Frigid temperatures for Monday; tracking overnight snow showers for Long Island
1:51
Doctors: Excessive scrolling on social media can have negative impact on brain health
0:28
MTA: Train strikes car near Central Islip; driver arrested for DWI
0:26
Police: Driver strikes pedestrian, flees scene in North Bellmore
0:21
